EUVIMEDEUVIMED entdecken
Crossref

Plasma-Activated Medium Selectively Kills Glioblastoma Brain Tumor Cells by Down-Regulating a Survival Signaling Molecule, AKT Kinase

Hiromasa Tanaka, Masaaki Mizuno, Kenji Ishikawa, Kae Nakamura, Hiroaki Kajiyama, Hiroyuki Kano, Fumitaka Kikkawa, Masaru Hori

Plasma Medicine · 2011

DOI: 10.1615/plasmamed.2012006275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Plasma Medicine, 2011. Verfasst von Hiromasa Tanaka und 7 weiteren Autor:innen. Die Arbeit wurde bisher 309-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tanaka, H., Mizuno, M., Ishikawa, K., Nakamura, K., Kajiyama, H., Kano, H., Kikkawa, F., & Hori, M. (2011). Plasma-Activated Medium Selectively Kills Glioblastoma Brain Tumor Cells by Down-Regulating a Survival Signaling Molecule, AKT Kinase. Plasma Medicine. https://doi.org/10.1615/plasmamed.2012006275

Vancouver

Tanaka H, Mizuno M, Ishikawa K, Nakamura K, Kajiyama H, Kano H, et al. Plasma-Activated Medium Selectively Kills Glioblastoma Brain Tumor Cells by Down-Regulating a Survival Signaling Molecule, AKT Kinase. Plasma Medicine. 2011. doi:10.1615/plasmamed.2012006275

BibTeX
@article{Tanaka2011,
  author = {Tanaka, Hiromasa and Mizuno, Masaaki and Ishikawa, Kenji and Nakamura, Kae and Kajiyama, Hiroaki and Kano, Hiroyuki and Kikkawa, Fumitaka and Hori, Masaru},
  title = {Plasma-Activated Medium Selectively Kills Glioblastoma Brain Tumor Cells by Down-Regulating a Survival Signaling Molecule, AKT Kinase},
  journal = {Plasma Medicine},
  year = {2011},
  doi = {10.1615/plasmamed.2012006275}
}
Kostenlos starten →